The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The Response of Metastatic Adenocarcinoma of the Prostate to Exogenous Testosterone
Abstract
In a retrospective review the response of 67 patient with metastatic adenocarcinoma of the prostate to the administration of exogenous testosterone was analyzed. Among 52 patients in whom objective and/or subjective responses were evaluable 45 experienced unfavorable responses. There was prompt regression of most unfavorable responses with testosterone withdrawal. The duration of treatment required to evoke an unfavorable response was related to the clinical status of the patient. Twenty-five per cent of patients with symptomatic metastases who had received no prior treatment, 36 per cent in symptomatic remission after endocrine therapy and 94 per cent with symptomatic relapse after endocrine therapy experienced unfavorable responses within 30 days of treatment. No patient had objective evidence of tumor regression during testosterone therapy but 7 patients, 6 with remission and 1 untreated, experienced symptomatic benefit. We conclude that the response of patients with metastatic prostate cancer to exogenous testosterone is related to the mass and endocrine treatment status, and that exogenous testosterone can stimulate prostatic neoplasms that proliferate in the absence of normal endogenous testosterone levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Testosterone: An Accurate Monitor of Hormone Treatment in Prostatic Cancer
SHEARER, R. J., HENDRY, W. F., SOMMERVILLE, I. F., & FERGUSSON, J. D. (1973) · British Journal of Urology · doi:10.1111/j.1464-410x.1973.tb12238.x · Cited by 163
Smolev, J. K., Heston, W., Scott, W. W., & Coffey, D. S. (1977) · PubMed · Cited by 130
Blackard, C. E. (1975) · PubMed · Cited by 84
Sinha, A. A., Blackard, C. E., & Seal, U. S. (1977) · Cancer · Cited by 69
Brendler, H. (1950) · Archives of Surgery · doi:10.1001/archsurg.1950.01250020438003 · Cited by 64
Mobbs, B. G., Johnson, I. E., Connolly, J. G., & CLARK, A. F. (1978) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(78)90620-9 · Cited by 44
The use of radioactive phosphorus to treat bone pain in metastatic carcinoma of the prostate.
Morales, A., Burr, R. C., & Bruce, A. W. (1970) · PubMed · Cited by 28
Cited by
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Gittes, R. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101243240406 · Cited by 738
Metadata
- Authors
- Fowler, J. E., & Whitmore, W. F.
- Venue
- Journal of Urology
- Published
- 1981-09
- Volume
- 126
- Issue
- 3
- Pages
- 372-375
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2276902499
- Cited by
- 261
- References
- 7
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Response of Metastatic Adenocarcinoma of the Prostate to Exogenous Testosterone. https://app.cochat.ai/papers/10.1016/s0022-5347(17)54531-0
- The paper
- Fowler, J. E., & Whitmore, W. F. (1981). The Response of Metastatic Adenocarcinoma of the Prostate to Exogenous Testosterone. Journal of Urology. https://doi.org/10.1016/s0022-5347(17)54531-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.